Dihydroartemisinin Unravels Dose-Dependent Transcriptomic Networks Orchestrating Ferroptosis and Metabolic Reprogramming in Colorectal Cancer
Current Issues in Molecular Biology · 25.03.2026 · 48 (4) · 342
DOI: 10.3390/cimb48040342 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 25.03.2026. Verfasst von Zhaodi Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Medical Imaging and Laboratory, Jining Medical University, Jining 272067, China. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical and Health Science and Technology Development Project of Shandong Province, Research Fund Project of Academician Helin Clinical Transformation Workstation of New Medicine.
Abstract (Originalsprache)
Background/Objectives: Dihydroartemisinin (DHA), a bioactive metabolite of Artemisia annua, displays potent antitumor activity in multiple cancers. However, its dose-dependent transcriptional regulatory networks in colorectal cancer (CRC) remain insufficiently understood. This study aimed to clarify the molecular mechanisms of low- and high-dose DHA in human CRC cells and reveal the dose-dependent crosstalk among related biological processes.
Methods
We integrated RNA-seq transcriptomic profiling and functional validation in HCT116 cells treated with 20 μM (low-dose) or 50 μM (high-dose) DHA. Differentially expressed genes (DEGs) were screened at FDR ≤ 0.05 and |log2(fold change)| ≥ 1, followed by GO and KEGG enrichment analyses.
Results
DHA inhibited cell viability dose-dependently, with an IC50 of 50 μM. We identified 280 and 678 DEGs in low-and high-dose groups, respectively. Low-dose DHA induced apoptosis via GADD45α/β and ATF4/DDIT3-mediated endoplasmic reticulum stress and triggered senescence through G2/M phase arrest. High-dose DHA mainly modulated gene expression signatures associated with ferroptosis by regulating iron homeostasis and lipid peroxidation at the transcriptional level. Both doses suppressed glycolysis, lipid, and folate metabolism; high-dose DHA also inhibited MGAT5B-mediated glycosylation. DHA regulated five core signaling pathways dose-dependently, with high-dose DHA further repressing Wnt3a/16 and BMP4/6.
Conclusions
This study first identifies ferroptosis-related gene networks as key transcriptional targets. It reveals dose-dependent crosstalk among cell death, senescence, metabolic reprogramming, and signaling, providing a transcriptomic framework and gene targets for optimizing DHA-based colorectal cancer therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medical Imaging and Laboratory, Jining Medical University, Jining 272067, China.
ORCID-Profile: Zhaodi Zheng, Xitan Hou
Förderung
- Medical and Health Science and Technology Development Project of Shandong Province
- Research Fund Project of Academician Helin Clinical Transformation Workstation of New Medicine
Zitieren
APA
Zheng, Z., Hou, X., Li, W., & Zhang, L. (2026). Dihydroartemisinin Unravels Dose-Dependent Transcriptomic Networks Orchestrating Ferroptosis and Metabolic Reprogramming in Colorectal Cancer. Current Issues in Molecular Biology, 48(4), 342. https://doi.org/10.3390/cimb48040342
Vancouver
Zheng Z, Hou X, Li W, Zhang L. Dihydroartemisinin Unravels Dose-Dependent Transcriptomic Networks Orchestrating Ferroptosis and Metabolic Reprogramming in Colorectal Cancer. Current Issues in Molecular Biology. 2026;48(4):342. doi:10.3390/cimb48040342
BibTeX
@article{Zheng2026,
author = {Zheng, Zhaodi and Hou, Xitan and Li, Wenjuan and Zhang, Leilei},
title = {Dihydroartemisinin Unravels Dose-Dependent Transcriptomic Networks Orchestrating Ferroptosis and Metabolic Reprogramming in Colorectal Cancer},
journal = {Current Issues in Molecular Biology},
year = {2026},
volume = {48},
number = {4},
pages = {342},
doi = {10.3390/cimb48040342}
}
EUVIMED